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Abstract. 
 
The transcription regulators, 
 
PDR1
 
 and 
 
PDR3
 
, have been shown to activate the transcription of 
numerous genes involved in a wide range of functions, 
including resistance to physical and chemical stress, 
membrane transport, and organelle function in 
 
Saccha-
romyces cerevisiae.
 
 We report here that 
 
PDR1
 
 and 
 
PDR3
 
 also regulate the transcription of one or more 
undetermined genes that translocate endogenous and 
 
fluorescent-labeled (M-C
 
6
 
-NBD-PE) phosphatidyleth-
anolamine across the plasma membrane. A combina-
tion of fluorescence microscopy, fluorometry, and 
quantitative analysis demonstrated that M-C
 
6
 
-NBD-PE 
can be translocated both inward and outward across the 
plasma membrane of yeast cells. Mutants, defective in 
the accumulation of M-C
 
6
 
-NBD-PE, were isolated by 
selectively photokilling normal cells that accumulated 
the fluorescent phospholipid. This led to the isolation 
of numerous trafficking in phosphatidylethanolamine 
(
 
tpe
 
) mutants that were defective in intracellular accu-
mulation of M-C
 
6
 
-NBD-PE. Complementation cloning 
and linkage analysis led to the identification of the 
dominant mutation 
 
TPE1-1
 
 as a new allele of 
 
PDR1
 
 
and the semidominant mutation 
 
tpe2-1
 
 as a new allele 
of 
 
PDR3.
 
 The amount of endogenous phosphatidyleth-
anolamine exposed to the outer leaflet of the plasma 
membrane was measured by covalent labeling with the 
impermeant amino reagent, trinitrobenzenesulfonic 
acid. The amount of outer leaflet phosphatidyletha-
nolamine in both mutant strains increased four- to five-
 
fold relative to the parent Tpe
 
1
 
 strain, indicating that 
the net inward flux of endogenous phosphatidyletha-
nolamine as well as M-C
 
6
 
-NBD-PE was decreased. Tar-
geted deletions of 
 
PDR1
 
 in the new allele, 
 
PDR1-11
 
, 
and 
 
PDR3
 
 in the new allele, 
 
pdr3-11
 
, resulted in normal 
M-C
 
6
 
-NBD-PE accumulation, confirming that 
 
PDR1-
11
 
 and 
 
pdr3-11
 
 were gain-of-function mutations in 
 
PDR1
 
 and 
 
PDR3
 
, respectively. Both mutant alleles re-
sulted in resistance to the drugs cycloheximide, oligo-
mycin, and 4-nitroquinoline 
 
N
 
-oxide (4-NQO). How-
ever, a previously identified drug-resistant allele, 
 
pdr3-2
 
, 
accumulated normal amounts of M-C
 
6
 
-NBD-PE, indi-
cating allele specificity for the loss of M-C
 
6
 
-NBD-PE 
accumulation. These data demonstrated that 
 
PDR1
 
 and 
 
PDR3
 
 regulate the net rate of M-C
 
6
 
-NBD-PE translo-
cation (flip-flop) and the steady-state distribution of 
endogenous phosphatidylethanolamine across the 
plasma membrane.
 
A
 
n
 
 asymmetric distribution of phospholipids across the
plasma membrane of cells has been documented
for numerous cell types (15, 16, 54). In all cells
where reliable measurements have been made, the major-
ity of phosphatidylserine and phosphatidylethanolamine
are located on the inner leaflet, whereas phosphatidylcho-
 
line, sphingomyelin, and glycolipids are located on the
outer leaflet. Regulation of the loss of this asymmetric dis-
tribution has been shown to function as a signal for several
important physiological processes, including platelet acti-
vation (39), clearance of senescent red cells (11), and pha-
gocytosis of apoptotic cells (17, 18). Apart from these in-
tercellular signaling functions, the role for the establishment
and regulation of an asymmetric distribution of phospho-
lipids across the plasma membrane of cells is not under-
stood. Although Mg
 
2
 
1
 
, ATP-dependent flip-flop of the
aminophospholipids, phosphatidylserine and phosphati-
dylethanolamine, by an aminophospholipid translocase is
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thought to be responsible for establishing their asymmet-
ric distribution, it is not known how many phospholipid
translocases are required or how they are regulated to es-
tablish the appropriate phospholipid distribution.
In this paper, we developed a genetic approach using the
yeast 
 
Saccharomyces cerevisiae
 
 to address these questions.
First, we characterized the influx and efflux pathways for
7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD)
 
1
 
-labeled phos-
phatidylethanolamine (M-C
 
6
 
-NBD-PE) and found that
influx occurred by a mechanism that has similar character-
istics to the flippase-mediated uptake of phosphatidyl-
ethanolamine in mammalian cells. Second, we developed a
novel method of mutant enrichment by dye-sensitized
photokilling and isolated new mutant alleles in two genes
(
 
PDR1
 
 and 
 
PDR3
 
) that result in the loss of M-C
 
6
 
-NBD-
PE accumulation in cells and an increase in the amount of
endogenous phosphatidylethanolamine in the outer leaflet
of the plasma membrane. Both 
 
PDR1
 
 and 
 
PDR3
 
 encode
transcription factors that activate the transcription of nu-
merous genes that confer resistance to a wide range of
drugs (5). The results indicated that 
 
PDR1
 
 and 
 
PDR3
 
 reg-
ulate phosphatidylethanolamine distribution across the
plasma membrane, presumably by increasing the tran-
scription of one or more undetermined genes that regulate
the net translocation (flip-flop) of phosphatidylethanol-
amine across the plasma membrane.
 
Materials and Methods
 
Materials
 
Yeast media were obtained from Difco Laboratories (Detroit, MI). Re-
striction enzymes and molecular biology reagents were purchased from
Life Technologies (Gaithersburg, MD). Unless otherwise noted, all other
reagents were purchased from Sigma Chemical Co. (St. Louis, MO).
 
Yeast Strains and Culture
 
The 
 
Saccharomyces cerevisiae
 
 strains used are shown in Table I. For all
experiments, early to mid-log phase cultures (OD
 
600
 
 
 
5
 
 0.2–1) were grown
from either overnight cultures or fresh plates in the indicated media as de-
scribed in Sherman et al. (44). The media used were: YPD, medium con-
taining 1% yeast extract, 2% glucose, 2% peptone; YEP-GE, medium
containing 1% yeast extract, 2% peptone, 2% glycerol, and 2% ethanol;
YP-Gal, medium containing 1% yeast extract, 2% galactose, 2% peptone;
SDC, synthetic complete media: 0.67% yeast nitrogen base, 2% glucose,
complete amino acid supplements; SCNaN
 
3
 
, SDC lacking glucose but con-
taining 2% sorbitol and 20 mM sodium azide. Temperature-sensitive
strains were grown at a permissive temperature of 23
 
8
 
C, and internaliza-
tion assays were performed at the nonpermissive temperature of 37
 
8
 
C.
Yeast transformations were performed as described by Gietz et al. (19).
 
Vesicle Preparation
 
M-C
 
6
 
-NBD-PE, M-C
 
6
 
-NBD-PC, dioleoylphosphatidylcholine (DOPC),
and 
 
N
 
-rhodamine-dioleoylphosphatidylethanolamine (
 
N
 
-Rh-DOPE) were
from Avanti Polar Lipids Inc. (Alabaster, AL). FM4-64 was purchased
from Molecular Probes, Inc. (Eugene, OR). Phospholipids were stored at
 
2
 
20
 
8
 
C, periodically monitored for purity by thin-layer chromatography
(TLC), and repurified when necessary. Phospholipid concentrations were
determined by lipid phosphorus assay (2). To prepare vesicles, lipids were
first mixed in desired proportions, and the chloroform was removed by
evaporation under nitrogen followed by overnight vacuum desiccation.
Desiccated lipids were then solubilized either in SDC medium or SDC
medium lacking glucose (for ATP-depletion experiments), and the mix-
ture was passed eight times through a Lipex Extruder (Lipex Biomem-
branes, Inc., Vancouver, BC, Canada) equipped with 0.1-mm filters to
produce vesicles. Total lipid concentration in the stock vesicle preparation
was 1 mM. Typically, proportions were 40 mol% NBD-labeled phospho-
lipid, 2 mol% 
 
N
 
-Rh-DOPE, and 58 mol% DOPC.
 
Internalization of Fluorescent Lipids into Yeast Cells
 
Cells were grown to mid-log phase in YPD or SDC at 30
 
8
 
C. Cells were
washed three times in SDC and resuspended at 
 
z
 
10
 
7
 
 cells/ml. Donor vesi-
cles containing 40% NBD-labeled phospholipid, 58% DOPC, and 2%
 
N
 
-Rh-DOPE (50 
 
m
 
M total lipid concentration) were added to the cells
and incubated for 30–120 min. Cells were washed three times with ice-cold
SCNaN
 
3
 
 before microscopy. Specific incubation conditions for the differ-
ent fluorescent lipids are as follows: Internalization experiments with
M-C
 
6
 
-NBD-PE typically entailed incubation with donor vesicles for 30 min
before microscopy. Experiments with M-C
 
6
 
-NBD-PC typically entailed
incubation for 2 h with the fluorescent lipid before microscopy. FM4-64
internalization experiments were performed by adding 1 
 
m
 
l of this dye
from a 1 mg/ml ethanolic stock solution to 1 ml of cells at 
 
z
 
1 
 
3
 
 10
 
7
 
/ml and
continuing incubation for 2 h before microscopy.
For M-C
 
6
 
-NBD-PE internalization experiments with 
 
sec
 
 mutants,
growth to mid-log phase was carried out at 23
 
8
 
C. Cultures were then split,
and half of the cells were warmed to the restrictive temperature of 37
 
8
 
C,
while the other half remained at 23
 
8
 
C. Warming to 37
 
8
 
C was accomplished
by gradually increasing the temperature over a period of 
 
z
 
10 min. After
shifting the temperature for 30 min, vesicles were added, and incubation
at 37
 
8
 
C was continued for 1 h. Cells were then transferred to an ice-water
bath and washed rapidly with ice-cold SCNaN
 
3
 
 medium in preparation for
microscopy. Controls were processed identically.
To quantitate the results with the 
 
sec
 
 mutants and their isogenic Sec
 
1
 
strains, 15 to 30 cells were analyzed for each of the strains at their permis-
sive (23
 
8
 
C) and nonpermissive (37
 
8
 
C) temperatures for growth. Although
there were strain to strain variations in M-C
 
6
 
-NBD-PE accumulation at
the permissive temperature for each isogenic pair, the difference in accu-
mulation at 23
 
8
 
C did not exceed 27%. The temperature-sensitive accumu-
lation of M-C
 
6
 
-NBD-PE for each strain was expressed as a ratio of the av-
erage pixel brightness at 37
 
8
 
C relative to 23
 
8
 
C. Inhibition of growth of the
 
sec
 
 mutants at 37
 
8
 
C was used to confirm the temperature-sensitive growth
phenotype of all of the 
 
sec
 
 strains used in these studies.
To deplete intracellular ATP, cells were incubated with shaking in
SCNaN
 
3
 
 for 45–50 min at 30
 
8
 
C before labeling as described above. We
have previously shown that this treatment results in 80% reduction in cel-
lular ATP levels (26). To test the effect of 
 
N
 
-ethylmaleimide (NEM)
treatment on M-C
 
6
 
-NBD-PE accumulation, mid-log phase cells were
cooled to 2
 
8
 
C, harvested by centrifugation, and resuspended in buffered
media (SDC containing 50 mM sodium phosphate buffer, pH 7.5) contain-
ing 2 mM NEM. Cells were incubated on ice for 30 min and were shaken
after the first 15 min. Cells recovered by centrifugation were resuspended
in buffered medium containing 2 mM DTT and incubated on ice for 5 min.
Cells were pelleted again, washed once with buffered medium, and resus-
pended in buffered medium before labeling with M-C
 
6
 
-NBD-PE as de-
scribed above. After labeling, cells were incubated on ice for 1.5 h and
washed three times with ice-cold SCNaN
 
3
 
 buffered with 50 mM sodium
phosphate, pH 7.5, before fluorescence microscopy.
 
Fluorescence Microscopy
 
Fluorescence microscopy was performed on a microscope (model Axio-
vert; Carl Zeiss, Inc., Thornwood, NY) equipped with barrier filters that
allowed no detectable crossover of NBD and rhodamine fluorescence. For
localization of 4
 
9
 
,6-diamidino-2-phenylindole (DAPI) fluorescence, bar-
rier filters were used that did not allow detectable crossover of NBD and
DAPI fluorescence. The fluorescence image was enhanced with an image-
intensifying camera (model SIT 66 or VE1000-SIT; DAGE-MTI, Inc.,
Michigan City, IN), digitized, and stored. Contrast enhancement and pixel
brightness analysis of the digital images were performed with Image-1/AT
or Metamorph software (Universal Imaging Corp., West Chester, PA).
 
1. 
 
Abbreviations used in this paper
 
: 4-NQO, 4-nitroquinoline 
 
N
 
-oxide;
DAPI, 4
 
9
 
,6-diamidino-2-phenylindol; DIC, differential interference contrast;
DOPC, dioleoylphosphatidylcholine; M-C
 
6
 
-NBD-PC, 1-myristoyl-2-[6-(NBD)
aminocaproyl]-phosphatidylcholine; M-C
 
6
 
-NBD-PE, 1-myristoyl-2-[6-(NBD)
aminocaproyl]-phosphatidylethanolamine; NBD, 7-nitrobenz-2-oxa-1,3-
diazol-4-yl; NBD-PE, 1-acyl-2-[6-(NBD) aminocaproyl]-phosphatidyleth-
anolamine; 
 
N
 
-Rh-DOPE, 
 
N
 
-rhodamine-dioleoylphosphatidylethanol-
amine; NEM, 
 
N
 
-ethlymaleimide; TLC, thin-layer chromatography; TNBS,
trinitrobenzenesulfonic acid; 
 
tpe
 
, trafficking of phosphatidylethanolamine. 
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Average pixel brightness was measured from a rectangle (1 
 
3
 
 3 pixels) in
the middle of vacuoles (for vacuolar labeling with M-C
 
6
 
-NBD-PC) or a
rectangle surrounding the entire cell (for all other labeling experiments).
Pixel brightness analysis of DOPC vesicles containing known amounts of
M-C
 
6
 
-NBD-PC confirmed that the measurements fell within the linear
range of the SIT camera. To confirm that the pixel brightness measure-
ments accurately reflected the amount of internalized M-C
 
6
 
-NBD-PE, la-
beled cells were extracted (22) and analyzed by TLC and fluorometry
(26). Fluorescence readings of the total extract as well as the TLC-purified
M-C
 
6
 
-NBD-PE were proportional to the pixel brightness measurements.
 
Trinitrobenzenesulfonic Acid Labeling
 
Cells were grown 18 h at 308C to mid-log phase (OD600 5 0.4–0.7) in SDC
containing 500 mCi of [32P]KH2PO4 (specific activity 1 Ci/mmol; New En-
gland Nuclear, Boston, MA). Plasma membrane, outer leaflet phosphati-
dylethanolamine was labeled with TNBS as described previously (30).
Cells were harvested by centrifugation, washed twice in ice-cold 40 mM
NaCl, 120 mM NaHCO3, pH 8.4, resuspended in the same buffer contain-
ing 5 mM trinitrobenzenesulfonic acid (TNBS) (Sigma Chemical Co.), and
immediately placed on ice for 1 h with periodic vortex mixing. After
TNBS labeling, cells were washed by centrifugation three times in fresh
buffer, pelleted, and disrupted by vortexing with glass beads. Cellular lipids
were extracted with chloroform/methanol (2:1) and separated by two-
dimensional TLC (first solvent: chloroform/methanol/ammonium hydrox-
ide, 65:35:5; second solvent: chloroform/methanol/acetone/acetic acid/water;
50:10:20:10:5). Spots were identified by comparison with known standards.
The percentages of phosphatidylethanolamine and TNP-phosphatidyleth-
anolamine were quantified by phosphorimaging with a PhosphorImager
SI scanning instrument (Molecular Dynamics, Sunnyvale, CA). Percent via-
bility was determined by counting the number of cells labeled after dilu-
tion into 0.02% methylene blue with a hemocytometer.
Isolation of Trafficking in Phosphatidylethanolamine 
(tpe) Mutants
Isogenic strains LKY6-2B (MATa) and CRY2 (MATa) were mu-
tagenized at 238C with ethylmethanesulfonate to 80% killing (27). For
dye-sensitized photokilling, mutagenized cells were grown to mid-log
phase in SDC at 238C before shifting to 378C for 30 min. Donor vesicles
(50 mM total lipid concentration) containing 40 mol% M-C6-NBD-PE
were then added as described above, and incubation continued for 30 min.
After the initial 30-min incubation, cells (7 ml at 1 3 107 cells/ml) were
transferred to a 60-mm Petri dish, which was placed in a chamber equili-
brated to 378C by a circulating water bath, and incubation was continued
for an additional 2 h (in the continuous presence of vesicles). During this
incubation, cells were irradiated with the light from a 150-W xenon lamp
(Second Source Inc., LaVerne, CA) that was passed through a narrow
band-pass filter at 470–480 nm, producing an intense blue light. After irra-
diation, cells were washed three times in SDC and either plated for single
colonies or incubated overnight at 238C in preparation for successive
rounds of photokilling. The temperature shift from 378C (incubation with
vesicles and irradiation) to 238C (growth overnight) allowed the potential
isolation of temperature-sensitive mutants. The tpe mutants were isolated
after five rounds of dye-sensitized photokilling.
Table I. Yeast Strains Used in This Study
Strain Genotype Source
CRY3* MATa Sec1 can1-100 ade2-1 his 3-11,15 leu2-3, 112 trpl-1 ura3-1 R.S. Fuller lab collection
MATa Sec1 can1-100 ade2-1 his3-11,15 leu2-3, 112 trpl-1 ura3-1
KRY78-4A  MATa Tpe1 can1-100 ade2-1 his3-11,15 leu2-3, 112 trp1-1 ura3-1 lys2 R.S. Fuller lab collection
CRY2* MATa Tpe1 can1-100 ade2-1 his3-11,15 leu2-3, 112 trpl-1 ura3-1 LYS2 R.S. Fuller lab collection
LKY6-2B MATa Tpe1 ade2 HIS3 ura3-1 lys2 This study
LKY118 MATa Tpe1 can1-100 ade2-1 HIS3- leu2-3, 112 trp1-1 ura3-1 lys2 This study
LKY115 MATa Tpe1 can1-100 ade2-1 his3-11,15 leu2-3, 112 trp1-1 ura3-1 LYS2 This study
LKY155 MATa TPE1-1 ade2-1 his3-11-15 ura3-1 LYS2 This study
LKY149 MATa TPE1-1 ade2-1 HIS3 ura3-1 lys2 This study
LKY141 MATa TPE1-2 ade2-1 HIS3 ura3-1 lys2 This study
LKY157 MATa tpe2-1 ade2-1 his3-11-15 ura3-1 LYS2 This study
LKY156 MATa tpe2-1 ade2-1 HIS3 ura3-1 lys2 This study
LKY161 MATa tpe2-1 ade2-1 HIS3 ura3-1 lys2 This study
AGY10 MATa ade8 J.W. Nichols lab collection
AGY124 pAG3 integrated into PDR3 locus in LKY161 This study
YYMI4-O3 MATa PDR3 trp1 his3 ura3 leu2 ade2 (parental strain of YYMI4-A4) K. Kuchler lab collection
YYMI4-A4‡ MATa pdr3-2 trp1 his3 ura3 leu2 ade2 K. Kuchler lab collection
YALA-G4§ MATa PDRI-3 ura3-52 leu2-3,112 his3-11,115 trp1-1 K. Kuchler lab collection
YALA-B1 MATa ura3-52 leu2-3,112 his 3-11,115 trp1-1 PDR1 K. Kuchler lab collection
YPH500 MATa ura3-52 leu2-D1 his3-D200 trp1-D63 ade2-101 lys2-801 
(parental strain of YKKB-13, YYM3 and YYM5)
K. Kuchler lab collection
YKKB-13 MATa ura3-52 leu2-D1 his3-D200 trp1-D63 ade2-101 lys2-801 Dpdr5::TRP1 K. Kuchler lab collection
YYM3 MATa ura3-52 leu2-D1 his3-D200 trp1-D63 ade2-101 lys2-801 Dsnq2::hisG Dpdr5::TRP1 K. Kuchler lab collection
YYM5 MATa ura3-52 leu2-D1 his3-D200 trp1-D63 ade2-101 lys2-801 Dsnq2::hisG K. Kuchler lab collection
NY13 MATa Sec1 ura3-52 P. Novick, Yale University
NY17 MATa sec6-4 ura3-52 P. Novick, Yale University
KRY30-2C* MATa sec1-1 can1-100 ade2-1 his3-11,15 leu2-3, 112 trp1-1 R.S. Fuller lab collection
KRY31-3C* MATa sec7-1 can1-100 ade2-1 his3-11,15 leu2-3, 112 trp1-1 R.S. Fuller lab collection
CWS11-2* MATa sec11 ade2-1 his2-11,15 leu2-3-112 trpl-1 ura3-1 R.S. Fuller lab collection
KRY33-2C* MATa sec14 can1-100 ade2-1 his3-11,15 leu2-3, 112 trp1-1 ura3-1 R.S. Fuller lab collection
CWS18-1 MATa sec18 can1-100 ade2-1 his3-11,15 leu2-3, 112 trp1-1 ura3-1 R.S. Fuller lab collection
X2180-1A MATa Sec1 SUC2 mal gal2 CUP1 Yeast Genetic Stock Center
SF266-1C MATa sec12-4 SUC2 mal gal2 CUP1 Yeast Genetic Stock Center
*Strains were derived from a nominally isogenic pair of strains, W303-1A (Mata can1-100 ade 2-1 his3-11,15 leu2-3, 112 trp1-1) and W3031B (W303-1A MATa) originally ob-
tained from R. Rothstein, Columbia University (50).
‡The pdr3-2 mutant allele was initially isolated by Guerineau et al. (20) and subsequently identified as an allele of PDR3 by Subik et al., 1986 (48).
§The PDR1-3 mutant allele was initially isolated as the T8 multidrug resistant nuclear allele of the strain DRI9 (20), subsequently renamed PDR1-3 (41).The Journal of Cell Biology, Volume 138, 1997 258
Drug Sensitivity Assays
1 mg/ml stock solutions of drugs were made by dissolving drugs in DMSO
or ethanol. Resistance to drugs such as cycloheximide, oligomycin, and
4-nitroquinoline-N-oxide was determined using the spot test assay. For
the spot test assay, 5-ml aliquots of yeast mid-log phase cultures (OD600 5
0.25) were spotted onto YPD plates containing the indicated concentra-
tions of cycloheximide or 4-nitroquinoline-N-oxide, or YPG plates con-
taining the indicated concentrations of oligomycin. Plates were incubated
for 3 d at 23, 30, or 378C.
Cloning of TPE2
The TPE2 gene was identified by its ability to complement the tempera-
ture-sensitive growth defect of tpe2-1 on nonfermentable carbon sources.
The tpe2-1 strain LKY161 was transformed with the yeast genomic library,
YPH1, which contains the selectable marker LEU2. Candidate TPE2
clones were identified based on their ability to restore growth of tpe2-1 on
SC-glycerol-ethanol plates lacking leucine at 378C. Only one plasmid was
isolated that was able to complement both the M-C6-NBD-PE accumula-
tion defect as well as the temperature-sensitive growth defect on nonfer-
mentable carbon sources of tpe2-1. This plasmid was designated p201.
p201 contained a 15-kb insert that sequencing revealed was a portion of
chromosome II spanning half of the SLA1 gene through approximately
one third of the ORF YBL004. Only two full-length ORFs are contained
within this region, PDR3 and an uncharacterized ORF YBL006.
To identify the portion of p201 responsible for complementing tpe2-1,
LKY161 was transformed with subclones of p201 containing either
YBL006 or PDR3. Integrative transformation with YBL006 did not com-
plement tpe2-1; however, transformation with PDR3 resulted in full com-
plementation of both the M-C6-NBD-PE accumulation defect as well as
the temperature-sensitive growth defect on nonfermentable carbon
sources. The strain transformed with PDR3 was designated AGY124.
Linkage analysis was used to determine whether the PDR3 was TPE2
(38). AGY124 was crossed to AGY10, a strain that is wild-type at the
TPE2 and LEU2 loci. All spores from this cross were wild-type for the PE
accumulation phenotype. This confirmed pAG3 integrated at the PDR3
locus and that TPE2 was linked to PDR3.
Disruption of PDR1 and PDR3
For disruption of the PDR3 gene, a 2.3-kb portion of the PDR3 coding re-
gion was removed by digestion with MunI and EcoRI and replaced with
the HisG-URA3-HisG cassette of the vector pNKY51 (1). To disrupt
PDR1, 2.2 kb of the coding region was removed by digestion with MunI
and replaced by the HisG-URA3-HisG cassette. Proper integration of the
disrupted alleles was confirmed by PCR or Southern blotting analysis.
Cloning and Sequencing of Mutant and Wild-Type 
PDR3 Alleles
PDR3 alleles were rescued using the method described by Winston et al.
(55). The alleles were obtained by integrative transformation of a YIp
vector near the PDR3 locus and subsequent eviction of a plasmid contain-
ing the vector along with the full-length PDR3 allele of interest. Plasmid
DNA was isolated from Escherichia coli transformants and the presence
of PDR3 alleles was confirmed by restriction digest analysis.
The nucleotide sequence of the entire open reading frame along with
an additional 400 bp upstream of the translation initiation codon and 250
bp downstream of the termination codon of each PDR3 allele was deter-
mined. Sequencing reactions were performed using the PRISM Dye Ter-
minator Cycle Sequencing Kit (Applied Biosystems, Inc., Foster City,
CA), an automated sequencer (model 373; Applied Biosystems, Inc.), and
a set of 12 16-mer primers designed to anneal to sequences z300 bp apart
in the PDR3 gene.
Statistical Analysis
Statistical analysis was performed with the InStat statistics software from
GraphPad Inc. (San Diego, CA). x2 analysis and two-tailed P values were
obtained from 3 3 2 contingency tables, or the Student’s t test was used to
compare the means and calculate a two-tailed P value from analysis of
variance.
Results
Analysis of M-C6-NBD-PE Influx and Efflux
When the diploid strain, CRY3, was incubated at 308C in
the presence of donor vesicles containing N-Rh-DOPE,
DOPC, and either M-C6-NBD-PE or M-C6-NBD-PC, the
rapidly exchangeable lipids, M-C6-NBD-PE and M-C6-
NBD-PC (33), were internalized (Fig. 1). The absence of
rhodamine fluorescence in the cells (not shown) indicated
that the nonexchangeable fluorescent lipid, N-Rh-DOPE
(35), was not internalized. Thus, the accumulation of intra-
cellular NBD fluorescence was not due to fusion of donor
vesicles or internalization of intact vesicles, but rather in-
ternalization of the NBD-phospholipid from the outer
leaflet of the plasma membrane after transfer from the do-
nor vesicles (26). Fig. 1 shows that M-C6-NBD-PC and
M-C6-NBD-PE are sorted to different organelles in yeast.
M-C6-NBD-PC was transported primarily to the vacuole
(the yeast lysosome) and, to a much smaller extent, to the
mitochondria and nuclear envelope (as previously docu-
mented, [26]), while M-C6-NBD-PE was excluded from
the vacuole and instead accumulated in the mitochondria
and nuclear envelope, as determined by colocalization
with DAPI (Fig. 2), and perhaps other unidentified or-
ganelles.
Fig. 3 shows a time course of M-C6-NBD-PE internaliza-
tion and efflux by a combination of fluorescence micros-
copy, spectrofluorometry, and quantitation after extrac-
tion and separation by TLC. The spectrofluorometric
internalization assay (Fig. 3 A) measured the increase in
NBD-fluorescence as M-C6-NBD-PE transferred from the
quenching environment of the donor vesicles to the non-
quenching environment of the yeast cellular membranes.
The accuracy of the spectrofluorometric assay, as well as
fluorescence microscopy digital imaging, to measure the
accumulation of M-C6-NBD-PE were confirmed by con-
comitant extraction and TLC separation. No degradation
products of M-C6-NBD-PE were detected in the cell ex-
tracts, indicating that only intact M-C6-NBD-PE was inter-
nalized and that either intracellular degradation was insig-
nificant or that degraded products were rapidly effluxed
from the cell. All three techniques illustrated that the net
amount of internalized M-C6-NBD-PE steadily increased
during an hour of incubation with the donor vesicles (Fig.
3, A and D).
After the net internalization of M-C6-NBD-PE, cells
were washed free of the donor vesicles and incubated at
308C with (Fig. 3, C and F) or without (Fig. 3, B and E) ex-
cess unlabeled acceptor vesicles, and the NBD fluores-
cence was monitored by the three techniques described
above. Since NBD fluorescence is highly sensitive to the
polarity of its immediate environment (32, 34), degrada-
tion of M-C6-NBD-PE to water-soluble products resulted
in almost complete loss of fluorescence. Thus, the data
presented in Fig. 3, B and E, illustrated a time-dependent
degradation of M-C6-NBD-PE. To determine whether the
degradation occurred intracellularly or was subsequent to
efflux from the cells, the rate of loss of cellular fluores-
cence and degradation were monitored in the presence of
excess unlabeled acceptor vesicles. Removal of the intact
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vesicles would be expected to prevent its degradation and
therefore inhibit the overall rate of loss of the fluorescence
signal. The result (Fig. 3, C and F) illustrated that concom-
itant with its loss from the cells, intact M-C6-NBD-PE ap-
peared in the acceptor vesicle–containing medium. This
result was confirmed by the slower rate of degradation de-
tected by fluorometry (Fig. 3 C). These data indicated that
intact M-C6-NBD-PE was effluxed from the cells and de-
graded. The existence of an extracellular phospholipase B
capable of hydrolyzing NBD-labeled lipids has been de-
scribed previously (28, 56). These data are consistent with
the interpretation that in the presence of excess M-C6-
NBD-PE–containing donor vesicles, the concurrent influx
and efflux resulted in net intracellular accumulation. Upon
removal of the donor vesicles, the net flux reversed, result-
ing in degradation of M-C6-NBD-PE by extracellular
phospholipases unless it was removed from the cell surface
by transferring to acceptor vesicles in the medium.
Similar results were obtained when the above experi-
ment was performed with the temperature-sensitive sec6-4
strain. At the nonpermissive temperature (378C), the
transport of secretory vesicles to the plasma membrane in
this strain is blocked, resulting in the accumulation of ex-
cess intracellular secretory vesicles (53). Numerous sec
mutants, including sec6-4, that inhibit vesicular traffic (36)
also inhibit the endocytic uptake of M-C6-NBD-PC (26)
and the lipophillic membrane probe, FM4-64 (52). Thus,
the observation that M-C6-NBD-PE internalization and
efflux occurred at rates similar to that observed in the
wild-type Sec1 strain (Fig. 3, A and C) indicated that
M-C6-NBD-PE influx was not dependent on the same
pathway as M-C6-NBD-PC and FM4-64 endocytosis nor
was its efflux dependent on secretion.
Additional sec mutant strains were tested for their abil-
ity to accumulate M-C6-NBD-PE by measuring the ratio
of M-C6-NBD-PE accumulation (measured by average
pixel brightness) at the nonpermissive temperature (378C)
to that at the permissive temperature (238C). This ratio for
sec1, 7, 11, 12, 14, and 18 ranged from 70 to 97% of their
isogenic Sec1 strains. Thus, M-C6-NBD-PE internalization
occurs even when the endocytosis of M-C6-NBD-PC and
FM4-64 are inhibited. In addition, the observations that
M-C6-NBD-PE is not transported to the vacuole (Figs. 1
and 2) and is not degraded intracellularly further support
the conclusion that M-C6-NBD-PE is internalized prima-
rily by a mechanism that does not require endocytosis.
Figure 1. M-C6-NBD-PC and M-C6-NBD-PE are sorted to different organelles in yeast. The diploid strain CRY3 was grown to mid-log
phase in SDC medium at 308C and incubated with donor vesicles containing 58 mol% DOPC, 2 mol% N-Rh-DOPE, and either 40
mol% M-C6-NBD-PC or 40 mol% M-C6-NBD-PE at 308C for 2 h (M-C6-NBD-PC) or 1 h (M-C6-NBD-PE). Microscopy was performed
as described in Materials and Methods. (A and C) Cells incubated with M-C6-NBD-PE. (B and D) Cells incubated with M-C6-NBD-PC.
(A and B) NBD fluorescence. (C and D) Differential interference contrast (DIC) optics. The identification of organelles colocalizing
with M-C6-NBD-PE fluorescence is shown in Fig. 2. Bar: 10 mm.The Journal of Cell Biology, Volume 138, 1997 260
M-C6-NBD-PE transport in yeast possessed many of the
same characteristics as NBD-labeled phosphatidylethanol-
amine sorting in mammalian cells. In addition to targeting
to the same intracellular organelles, M-C6-NBD-PE trans-
port in yeast was inhibited by ATP depletion, low temper-
ature, and NEM treatment (Fig. 4). Preincubation of the
CRY2 strain with SCNaN3 medium depleted cellular ATP
by 80% (26) and reduced the accumulation of M-C6-NBD-
PE to 7% of the pixel brightness of the untreated control
cells. Incubation at 28C reduced accumulation to 10% of
controls. Pretreatment and labeling of CRY2 cells at 28C
in the presence of 2 mM NEM further reduced the pixel
brightness to 4%. The similarity of these characteristics of
M-C6-NBD-PE traffic in yeast to NBD-labeled phosphati-
dylethanolamine traffic in mammalian cells suggests that it
is translocated across the yeast plasma membrane by a
protein analogous to the mammalian aminophospholipid
translocase (31, 45, 49).
Isolation of Mutants That Do Not
Accumulate M-C6-NBD-PE
We developed a novel scheme for isolating yeast mutants
(referred to as tpe mutants) that were defective in the ac-
cumulation of M-C6-NBD-PE. As shown above (Figs.
1–3), wild-type yeast cells became highly fluorescent when
they internalized M-C6-NBD-PE. Exposure of the labeled
cell cultures to intense light between 470–480 nm (the ex-
citation maximum for NBD) for 2 h resulted in the death
of .95% of the cells. Photokilling required both incuba-
tion with vesicles and illumination. Elimination of either
incubation condition eliminated the photokilling. Mu-
tagenized cultures were subjected to five “rounds” of pho-
tokilling enrichment (described in detail in Materials and
Methods) and then plated for single colonies. Individual
colonies were examined microscopically for defects in
M-C6-NBD-PE accumulation. Testing multiple individual
colonies that grew on rich medium containing glucose
(YPD medium) after five rounds of dye-sensitized photo-
killing revealed a .25:1 ratio of tpe mutants/wild-type sur-
vivors. 8–10 Tpe2 survivors from each independently mu-
tagenized culture were saved for further analysis.
Fig. 5 shows the phenotype of tpe mutants representing
two different complementation groups (see analysis be-
low) obtained from the photokilling enrichment. After in-
cubation with donor vesicles containing M-C6-NBD-PE,
tpe mutants showed no fluorescence when microscopy was
performed with a neutral density filter that allowed 5% of
the light from a 100-W lamp to reach the sample, although
in the Tpe1 parent strain, highly fluorescent mitochondria
and nuclear envelopes were apparent (Fig. 5, compare A
and D). When the neutral density filter was removed, low
levels of intracellular and cell surface fluorescence could
be observed in both tpe mutants, whereas fluorescent
emission from the Tpe1 cells was oversaturated (Fig. 5,
compare B, E, and H). Inhibition of the M-C6-NBD-PE
accumulation into the tpe mutants detected by fluores-
cence microscopy was confirmed by extraction of total cel-
lular lipids and recording of total NBD fluorescence in the
extract as well as the fluorescence of M-C6-NBD-PE puri-
fied from the extract by TLC. Thus, the lack of fluores-
cence detected by microscopy reflected a quantitative de-
crease in M-C6-NBD-PE cellular accumulation, and the
“ring staining” pattern in the tpe mutants presumably re-
Figure 2. M-C6-NBD-PE is sorted to the mitochondria and nuclear envelope from the yeast plasma membrane. CRY3 was grown to
mid-log phase in SDC medium at 308C and incubated with M-C6-NBD-PE–containing vesicles for 1 h as described in Materials and
Methods. Colocalization of NBD fluorescence with DAPI fluorescence of nuclear and mitochondrial DNA was performed by including
2.5 mg/ml DAPI with the M-C6-NBD-PE–containing vesicles. Top row, NBD fluorescence; middle row, DAPI fluorescence; bottom row,
DIC optics. Solid arrows point to nuclear envelope (NBD fluorescence) and nuclear DNA (DAPI fluorescence); open arrows point to
mitochondria (NBD fluorescence) and mitochondrial DNA (DAPI fluorescence). Bar, 10 mm. 
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accumulation defect. Two independent isolates from the
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were selected for further characterization. These three
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 phenotypes segregated 2:2 in each of the nine
tetrads analyzed per back-cross for all three Tpe
 
2
 
 
 
strains,
indicating that for each 
 
tpe
 
 allele, a single gene was re-
Figure 3. Cellular M-C6-NBD-PE influx and efflux measured by fluorescence microscopy, fluorometry, and quantitative TLC. CRY2
was grown to mid-log phase in SDC medium at 308C. NY17 (sec6-4) was grown to mid-log in SDC at room temperature (z238C). The
sec6-4 cells were warmed to 378C for 30 min before labeling with M-C6-NBD-PE and were treated identically to the CRY2 cells as de-
scribed below with the exception that they were maintained at 378C during influx and efflux instead of 308C. CRY2 cells were pelleted
and resuspended in SDC 1 2% sorbitol at OD600 5 0.16. Labeling of cells was initiated by the addition of M-C6-NBD-PE–containing
donor vesicles (vesicle phospholipid concentration, 50 mM). A 2-ml aliquot was immediately placed in a stirred fluorometer cuvette at
308C and NBD fluorescence (excitation, 475 nm; emission, 530 nm) was recorded continuously. The remainder were placed in a shaker
incubator at 308C. Aliquots were removed at the indicated times and washed three times in SCNaN3. A small aliquot was removed for
fluorescence microscopy and the remainder were extracted, separated by TLC, and quantified by digital imaging of the M-C6-NBD-PE
fluorescent spots. After 1 h, the remaining labeled cells were washed three times in ice-cold SDC 1 2% sorbitol. Measurement of M-C6-
NBD-PE in the cells and medium post labeling was initiated by returning the cells to 308C in the shaker incubator in the presence or ab-
sence of unlabeled DOPC vesicles (50 mM). 2-ml aliquots were removed and placed in the fluorometer for continuous recording as
above. Aliquots were removed at the indicated times for fluorescence microscopy, TLC separation and quantification as described
above. (A and D) Labeling in the presence of M-C6-NBD-PE donor vesicles. (B and E) Post labeling in the absence of acceptor vesicles.
(C and F) Post labeling in the presence of acceptor vesicles. Images in D–F are of CRY2 cells only. The appearance of the sec6-4 cells
were similar and are not shown. Solid lines are fluorometer traces adjusted to 100% of maximum signal. Filled symbols refer to ex-
tracted, cell-associated M-C6-NBD-PE; open symbols refer to the M-C6-NBD-PE extracted from the supernatant. Circles, CRY2; squares,
sec6-4. Bar, 10 mm.
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sponsible for the Tpe2 phenotype. Diploids containing
one Tpe1 and one Tpe2 allele were not capable of accu-
mulating M-C6-NBD-PE to wild-type levels. Diploids re-
sulting from crosses of the two isolates from the first com-
plementation group to their isogenic parent strain remained
defective in M-C6-NBD-PE accumulation, and thus, these
two mutant alleles appeared to be dominant. The isolate
from the second complementation group when crossed to
its parent strain showed a partial defect in M-C6-NBD-PE
accumulation and was considered to be semidominant.
The two dominant Tpe2 strains were assigned to the TPE1-1
and TPE1-2 (capitals to denote dominance) complemen-
tation group and the semidominant strain was assigned to
tpe2-1.
tpe Mutants Are Temperature-sensitive for
Oxidative Phosphorylation
Growth of TPE1-1 and tpe2-1 mutants was temperature-
sensitive on nonfermentable carbon sources (Fig. 6), indi-
cating a temperature-sensitive loss of respiratory function
in the mutants. After the third back-cross of TPE1-1,
TPE1-2, and tpe2-1, the segregation pattern of the respira-
Figure 4. M-C6-NBD-PE transport in yeast is ATP-, tempera-
ture- and NEM-sensitive. Cells were treated with SCNaN3 me-
dium (to deplete ATP stores), low temperature, or NEM as de-
scribed in Materials and Methods. M-C6-NBD-PE internalization
assays, fluorescence microscopy, and pixel brightness analysis
were then performed as described in Materials and Methods. At
least 20 cells were analyzed to determine the mean pixel bright-
ness for each condition. These numeric values are shown above
each column.
Figure 5. tpe mutants are in-
hibited in the accumulation
of M-C6-NBD-PE. TPE1-1
and its Tpe1 parent strain,
CRY2, were grown to mid-
log phase at 238C. The incu-
bation temperature was then
shifted to 378C for 30 min,
and M-C6-NBD-PE internal-
ization assays were per-
formed for 1 h before micro-
scopic analysis as described
in Materials and Methods.
(A–C) CRY2. (D–F) TPE1-1.
(G–I) tpe2-1. (A, B, D, E, G,
and  H) NBD fluorescence.
(C,  F, and I) DIC optics. In A
and D, a neutral density filter
was used that attenuated the
excitatory light by 95%. In B
and E, the filter was removed
to allow 100% of the excita-
tory light to impinge upon
the sample.Kean et al. Regulation of Phosphatidylethanolamine Flip-Flop 263
tory deficiency phenotype (Respiratory2) was determined.
In each of the nine tetrads dissected for each mutant allele,
Respiratory1/Respiratory2 segregated 2:2, indicating that
a single gene was responsible for this phenotype. Further-
more, the Respiratory2 and M-C6-NBD-PE-accumulation
defect cosegregated in 100% of the tetrads analyzed, indi-
cating that the same gene or a tightly linked gene was re-
sponsible for both phenotypes. tpe2-1 exhibited a more se-
vere respiration defect than the TPE1-1 mutant, being
unable to grow on glycerol/ethanol medium (YEP-GE
medium) (Fig. 6) or lactate (not shown) at 308C, whereas
the TPE1-1 mutant exhibited this growth defect only at
378C. Both TPE1-1 and tpe2-1 mutants grew on YEP-GE
medium at 238C and on the fermentable carbon sources
glucose (YPD medium) (Fig. 6) and galactose (YP-Gal
medium) (not shown) at 23, 30, and 378C. TPE1-1/tpe2-1
double mutants exhibited synthetic lethality in that growth
on YPD at 378C and growth on YP-glycerol at 238C was
inhibited (not shown).
Although the tpe mutants did not arrest when grown in
fermentable carbon sources at 378C, they did exhibit
growth defects under these conditions. Growth of TPE1-1
and tpe2-1 in YP-Gal was slowed twofold compared to the
isogenic Tpe1 strains, and growth on glucose was reduced
by 1.6-fold in rich media (YPD) and fivefold in synthetic
media (SDC). Thus, although the growth defects at 378C
in the tpe mutants were predominantly manifested on non-
fermentable carbon sources, to some extent growth de-
fects were observed on all media tested.
The Percentage of Endogenous 
Phosphatidylethanolamine Exposed to the Outer Leaflet 
of the Plasma Membrane Is Increased in the
tpe Mutants
To determine whether the transport of M-C6-NBD-PE
across the plasma membrane was indicative of the behav-
ior of endogenous phosphatidylethanolamine, the amount
of phosphatidylethanolamine in the outer leaflets of
TPE1-1,  tpe2-1, and their parent Tpe1 strain was mea-
sured by labeling with TNBS using membrane imper-
meant conditions. The percentage of TNP-labeled phos-
phatidylethanolamine increased four to fivefold in both
mutants relative to the Tpe1 strain (Table II). Thus, the
amount of phosphatidylethanolamine in the outer leaflet
of the plasma membrane increased in the mutant strains
consistent with a decrease in the net influx rate of endoge-
nous phosphatidylethanolamine as well as M-C6-NBD-PE.
tpe Mutants Are Defective in
Membrane-Lipid Endocytosis
The effect of the tpe mutations on endocytosis was tested
for two different membrane markers. M-C6-NBD-PC (26)
and FM4-64 (52) have been shown previously to be en-
docytosed to the vacuole in S. cerevisiae. As shown in Ta-
ble III, rows B and C, accumulation of both probes was in-
hibited to similar extents in the tpe mutants relative to the
parent strain. Although the extent of accumulation of both
probes was attenuated, FM4-64 and M-C6-NBD-PC fluo-
rescence was localized to the vacuolar membrane and lu-
men, respectively (data not shown). Thus, there was a gen-
eralized defect in endocytosis of membrane-lipids in the
tpe mutants. It is important to note that although endocy-
tosis was inhibited in the tpe mutants, it was not reduced as
severely as was the nonendocytic traffic of M-C6-NBD-PE.
Figure 6. TPE1-1 and tpe2-1 display temperature-sensitive
growth defects on nonfermentable carbon sources. TPE1-1, tpe2-1,
and CRY2 were plated on rich media containing both a ferment-
able carbon source (2% glucose) (YPD), or the nonfermentable
carbon sources glycerol (2%) and ethanol (2%) (YEP-GE).
Plates were incubated for 2 d (308 and 378C plates) or 4 d (238C)
before photography.
Table II. TNBS Labeling of Phosphatidylethanolamine in the 
Outer Leaflet of the Plasma Membrane
Strains
CRY2
TPE1-1/
PDR1-11
tpe2-1/
pdr3-11
Phosphatidyl-
ethanolamine
98.2 6 0.4 91.8 6 1.5 90.3 6 1.5
TPN-phosphatidyl-
ethanolamine
1.8 6 0.4 8.2 6 1.5 9.7 6 1.4
32P-labeled cells were reacted with TNBS on ice, washed, extracted, and separated by
TLC as described in Materials and Methods. The percentages of phosphatidylethanol-
amine and TNP-phosphatidylethanolamine were determined by phosphorimaging
analysis. The percentage of viable cells was 96.1 6 0.4, 98.2 6 0.5, and 95. 1 6 0.4
for CRY2, TPE1-1, and tpe2-1, respectively. Data are reported as the mean and stan-
dard error of four independent analyses from one experiment that was representative of
three.The Journal of Cell Biology, Volume 138, 1997 264
Estimates of the extent of M-C6-NBD-PC uptake com-
pared to M-C6-NBD-PE by pixel brightness analysis
showed that there was at least a 10-fold greater accumula-
tion of M-C6-NBD-PC than M-C6-NBD-PE in the tpe mu-
tants at 378C (Table III, rows A and B).
The nonspecific internalization in the TPE1-1 and tpe2-1
strains of other amphipathic fluorescent probes, including
DAPI and 3,39-dihexyloxacarbocyanine iodide (DiOC6)
(data not shown), to the same level as their isogenic parent
strains indicated that inhibition of NBD-lipid accumula-
tion was not due to a nonspecific block of internalization
of all lipophillic molecules.
tpe Mutants are Drug Resistant
Given the identification of MDR1 and MDR2 as phospho-
lipid transporters (40, 46, 51), we tested the possibility that
the sorting defects in the tpe mutants were due to the up-
regulation of an MDR-like efflux pump. Activation of a
variety of MDR homologues in yeast leads to increased re-
sistance to a large array of drugs because of enhanced ef-
flux of these drugs from the cells (5, 7). If the tpe pheno-
type resulted from an activated MDR-like pump, mutants
would also be expected to display increased drug-resistant
phenotypes. We therefore tested the sensitivity of TPE1-1,
tpe2-1, and their parent Tpe1 strains to three structurally
unrelated drugs, oligomycin, 4-nitroquinoline N-oxide
(4-NQO), and cycloheximide, using a spot test assay (see
Materials and Methods). Resistance to cycloheximide and
4-NQO has been shown to result primarily from the ampli-
fication of the ABC transporters, Pdr5p and Snq2p, re-
spectively (12, 24, 29). Resistance to oligomycin is at least
partly due to the amplification of Yor1p (25).
Table IV shows that both TPE1-1 and tpe2-1 are resis-
tant to 4-NQO and cycloheximide at 308C and are resis-
tant to oligomycin at 238C, compared to the isogenic Tpe1
strain. The isogenic Tpe1 strain does not grow on YPD
plates containing 0.2 mg/ml cycloheximide or greater; how-
ever, both tpe mutants grow on plates containing 1 mg/ml
cycloheximide (Table IV). TPE1-1 shows a slightly greater
resistance to oligomycin and 4-NQO than tpe2-1; however,
they both are significantly more resistant than the Tpe1
strain (Table IV). The relative resistance of TPE1-1 and
tpe2-1 to cycloheximide and 4-NQO was similar at 23, 30,
and 378C. Tests of oligomycin resistance required growth
on a nonfermentable carbon source. Therefore, because of
the temperature-sensitive growth defect of the mutants,
tests were limited to 238C.
Identification of TPE2 and TPE1
Complementation of the temperature-sensitive growth de-
fect on nonfermentable carbon sources of tpe2-1 was used
to isolate the TPE2 gene (see Materials and Methods).
Transformation with PDR3 resulted in full complementa-
tion of the M-C6-NBD-PE accumulation defect (Fig. 7 A),
cycloheximide resistance (Fig. 7 B), and the temperature-
sensitive growth defect on nonfermentable carbon sources
of tpe2-1 (data not shown). Linkage analysis determined
that tpe2-1 was allelic with PDR3 (38). PDR3 has been
identified as a transcriptional activator of the pleiotropic
drug resistance network (14).
We hypothesized that TPE1 was identical to PDR1 and
therefore tested the linkage of these two genes based on
the following three observations: (a) TPE2 and PDR3
were determined to be identical; (b) PDR1 is a transcrip-
tional activator of the drug resistance network and is ho-
mologous to PDR3 (5); and (c) TPE1-1 is drug resistant
(Table IV). Tetrad analysis of TPE1-1 and PDR1-3 for cy-
cloheximide resistance indicated that TPE1 and PDR1
were tightly linked.
TPE1-1 and tpe2-1 Are Respective Gain-of-Function 
Alleles of PDR1 and PDR3
To test the predicted identity of TPE1 with PDR1 and
TPE2 with PDR3, the nonessential genes PDR1 and
PDR3 were deleted in both tpe mutant strains. Deletion of
Table III. Internalization of NBD-labeled Lipids and FM4-64 
into Mutant and Wild-Type Yeast Strains
Strains
CRY2 TPE1-1/PDR1-11 tpe2-1/pdr3-11
A M-C6-NBD-PE 100 6 16 1 6 1 0.3 6 0.3
B M-C6-NBD-PC 100 6 38 12 6 3 18 6 8
C FM4-64 100 6 58 35 6 23 36 6 24
Yeast strains were grown to mid-log phase, and lipid internalization assays, micros-
copy, and pixel brightness analysis were perfomed as described in Materials and
Methods. For each determination, the mean pixel brightness of 10–38 cells and stan-
dard deviation were determined. For each internalization condition, the pixel bright-
ness of CRY2 was set to 100%, and the pixel brightness in the other strains is shown
as a percentage of this value. The pixel brightness of CRY2 under the various incuba-
tion conditions was: (A) 177 6 28; (B) 132 6 50; (C) 12 6 7.
Table IV. Drug Resistance Phenotypes of tpe and pdr Strains
CYH Oligomycin 4-NQO
mg/ml mg/ml mg/ml
Strains 0.2 0.5 1.0 0.3 0.5 1.0 0.5 0.8 1.0
CRY2 (TPE2 TPE1) 2 2 2 2 2 2 1/2 2 2
LKY161 (tpe2-1/pdr3-11) 1 1 1/2 1 1 2 1 1 1/2
LKY155 (TPE1-1/PDR1-11) 1 1 1/2 1 1 1 1 1 1
YYMI4-O3 (PDR3) 2 2 2 2 2 2 1/2 2 2
YYMI4-A4 (pdr3-2) 1 1 1/2 2 2 2 1/2 1/2 2
YALA-B1 (PDR1) 2 2 2 2 2 2 1/2 2 2
YALA-G4 (PDR1-3) 1 1 1/2 1 1 2 1 1 1
The growth of strains spotted on YPD plates containing 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, and 1.0 mg/ml of cycloheximide (CYH) or 4-nitroquinoline-N-oxide (4-NQO) or
YPG plates containing the same concentrations of oligomycin was scored after 3–4 d of growth at 308C for YPD plates and 238C for YPG plates. 1, normal growth; 2, no growth;
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PDR1 in the TPE1-1 mutant strain restored wild-type lev-
els of M-C6-NBD-PE accumulation (Fig. 8) and cyclohex-
imide sensitivity (data not shown). Similarly, PDR3 dele-
tion in the tpe2-1 strain also restored wild-type levels of
M-C6-NBD-PE accumulation and cycloheximide sensitiv-
ity. Conversely, deletion of PDR1 in tpe2-1 and deletion of
PDR3 in TPE1-1 had no effect on either mutant pheno-
type. These data indicated that TPE1-1 is a gain-of-func-
tion mutant allele of PDR1, and tpe2-1 is a gain-of-function
mutant allele of PDR3. Consistent with this interpretation,
deletion of PDR1 and PDR3 in the parental Tpe1 strain
resulted in wild-type levels of M-C6-NBD-PE accumula-
tion and cycloheximide sensitivity (data not shown). From
this point on, TPE1-1 will be referred to as PDR1-11, and
tpe2-1 will be referred to as pdr3-11.
The Defect in M-C6-NBD-PE Accumulation in PDR3 
Is Allele Specific
The strain carrying the mutant allele pdr3-2 was originally
isolated based on its resistance to chloramphenicol and cy-
cloheximide (20) and subsequently identified as an allele
of PDR3 (48). This strain was compared to the tpe2-1/
pdr3-11 allele in relation to M-C6-NBD-PE accumulation
and drug resistance (Fig. 9, Table IV). Allele specificities
were observed in both. Unlike tpe2-1/pdr3-11, pdr3-2 did
not exhibit a defect in M-C6-NBD-PE accumulation; how-
ever, both alleles exhibited similar resistance to cyclohex-
imide (Table IV). pdr3-2 was also less resistant to 4-NQO
and oligomycin than tpe2-1.
The PDR3 mutant allele, tpe2-1/pdr3-11, was rescued by
integrative transformation followed by plasmid eviction of
Figure 7. Complementation of tpe2-1 by PDR3. The tpe2-1 strain LKY161 was transformed with either the plasmid pRS405 alone or the
pRS405 plasmid containing the PDR3, pRS405-PDR3. Four transformants from each transformation were grown to mid-log phase in
SDC medium lacking leucine at 238C. (A) 1 ml of each culture was incubated at 308C for 30 min, and M-C6-NBD-PE internalization as-
says and fluorescence microscopy were performed as described in Materials and Methods. (a–c) tpe2-1 transformed with vector pRS405
alone. (d–f) tpe2-1 transformed with pRS405-PDR3. (a, b, d, and e) NBD fluorescence. (c and f) DIC optics. In a and d, a neutral density
filter was used that attenuated the excitatory light by 95%. In b and e, the neutral density filter was removed to allow 100% of the exci-
tatory light to reach the samples. The M-C6-NBD-PE accumulation of the cells shown in this figure are representative of that observed
for all four transformants analyzed. (B) 5 ml of each culture was spotted onto SDC plates lacking leucine and containing 0 (not shown),
0.25, 0.50, or 0.75 mg/ml cycloheximide and incubated at 308C for 3 d.The Journal of Cell Biology, Volume 138, 1997 266
the mutant allele. Sequencing revealed a single point mu-
tation. Glycine957, which is predicted to be in the activation
domain, was replaced by an aspartate.
Discussion
Model for M-C6-NBD-PE Translocation
The data presented here provide evidence that M-C6-
NBD-PE is internalized into yeast by a mechanism that is
distinct from the major pathway for M-C6-NBD-PC inter-
nalization. This mechanism is detailed in the model shown
in Fig. 10. In step 1, M-C6-NBD-PE molecules dissociate
from donor vesicles and insert in the outer leaflet of the
yeast plasma membrane. Even though M-C6-NBD-PE
molecules are predominantly membrane bound (their mo-
lar concentration in the membrane is 107 times greater
than their concentration in water [33]), they rapidly ex-
change through the medium between membranes (t1/2 5
z2 s at 258C [33]). Furthermore, by incorporating a “non-
Figure 8. Deletion of PDR1 in TPE1-1 and PDR3 in tpe2-1 suppresses their M-C6-NBD-PE accumulation defect. Strains were grown to
mid-log phase in SDC medium at 238C. 1 ml of each culture was incubated at 378C for 30 min and M-C6-NBD-PE internalization assays
and fluorescence microscopy were performed as described in Materials and Methods. (A–C) tpe2-1 Dpdr3. (D–F) TPE1-1 Dpdr3. (G–I)
tpe2-1 Dpdr1. (J–L) TPE1-1 Dpdr1. (A, B, D, E, G, H, J, and K) NBD fluorescence. (C, F, I, and L) DIC optics. In A, D, G, and J, a neu-
tral density filter was used that attenuated the excitatory light by 95%. In B, E, H, and K, the neutral density filter was removed to allow
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exchangeable” fluorescent lipid (N-Rh-DOPE) into the
donor vesicles, we determined that the cell-associated flu-
orescence was not due to donor vesicle fusion or internal-
ization, but rather due to the movement of monomers of
M-C6-NBD-PE from the donor vesicles into the plasma
membrane.
Translocation across the plasma membrane (step 2) is
modeled as protein mediated based on the inhibition of
M-C6-NBD-PE accumulation by treatment with NEM at
low temperature. Inhibition of M-C6-NBD-PE accumula-
tion by depletion of intracellular ATP indicates a yet to be
defined requirement for cellular ATP or another nucle-
otide in the translocation process. Given the relatively
high partition coefficient of M-C6-NBD-PE (33), the flip-
Figure 9. The inhibition of M-C6-NBD-PE accumulation by mutations in PDR3 is allele specific. pdr3-2 and tpe2-1/pdr3-11 strains were
grown to mid-log phase in SDC medium at 238C. 1 ml of each culture was incubated at 378C for 30 min and M-C6-NBD-PE internaliza-
tion assays and fluorescence microscopy were performed as described in Materials and Methods. (A–C) tpe2-1/pdr3-11. (D–F) pdr3-2.
(A, B, D, and E) NBD fluorescence. (C and F) DIC optics. In A and D, a neutral density filter was used that attenuated the excitatory
light by 95%. In B and E, the neutral density filter was removed to allow 100% of the excitatory light to reach the samples.
Figure 10. Schematic model
for the regulation of M-C6-
NBD-PE flip-flop and sorting.The Journal of Cell Biology, Volume 138, 1997 268
pase model, in which an amphiphile partitions into one
leaflet of a membrane and its polar group is flipped to the
other side (21), is the most likely mechanism to explain
M-C6-NBD-PE translocation across the plasma mem-
brane. These characteristics of M-C6-NBD-PE internaliza-
tion in yeast are similar to the characteristics of the flip-
pase-mediated phosphatidylethanolamine uptake that has
been described in mammalian cells (10, 31, 42) and yeast (3).
Our results show that the predominant pathway for
M-C6-NBD-PE internalization occurs even when lipid en-
docytosis is inhibited. M-C6-NBD-PE is not delivered to
the vacuole like other lipid markers that are internalized
by endocytosis, nor is its internalization inhibited in sec
mutants shown previously to inhibit lipid-endocytosis (26,
52). However, although M-C6-NBD-PE accumulation oc-
curs when endocytosis is inhibited, our results do not ex-
clude the possibility that under normal conditions, topo-
logical translocation of M-C6-NBD-PE to the cytoplasmic
surface also occurs subsequently to the early steps of en-
docytosis.
After translocation to the cytoplasmic leaflet of the
plasma membrane or endocytic vesicle, M-C6-NBD-PE is
transported to intracellular organelles including, but not
necessarily limited to, the nuclear envelope and mitochon-
dria (step 4). Given the rapid rate of exchange of M-C6-
NBD-PE between membranes measured in vitro (33), it is
likely that transfer from the inner leaflet of the plasma
membrane to other intracellular organelles occurs sponta-
neously. However, the different organelle membranes are
not labeled to the same extent. For example, M-C6-NBD-
PE labeling was clearly seen in the mitochondria and nu-
clear envelope but never in the vacuolar membrane. Thus,
the rapidly exchanging M-C6-NBD-PE molecules appeared
to be sorted into distinct organelle membranes. The ob-
served sorting may result from directed transport to spe-
cific organelles or it may reflect an equilibrium distribution
determined by the properties of the organelle membranes.
At this time, the mechanisms responsible for the apparent
nonuniform labeling of the intracellular membranes is un-
known.
In addition to its endocytosis-independent internaliza-
tion, our results also provide evidence (Fig. 3) for the ef-
flux of intact M-C6-NBD-PE molecules from yeast cells
(step 3). It is important to realize that although we monitor
this efflux only after the cells are loaded with M-C6-NBD-PE,
influx and efflux are likely occurring concurrently. In the
presence of medium containing excess M-C6-NBD-PE donor
vesicles (Fig. 3, A and D), the balance leads to intracellular
accumulation of fluorescent lipid. When these donor vesi-
cles are removed, the balance shifts to favor a depletion of
intracellular fluorescence. Our data do not distinguish
whether a single protein is responsible for both influx and
efflux, or whether influx and efflux are mediated in differ-
ent directions by different proteins.
Relevance of Short Acyl Chain,
NBD-labeled Phospholipid Trafficking to Endogenous 
Phospholipid Trafficking
Although NBD-labeled lipids have been used for many
years to study lipid sorting and trafficking in cultured cells
(37), one must consider the extent to which the presence
of the NBD group and/or the truncation of the sn-2 acyl
chain alters the behavior of the phospholipid analogue rel-
ative to its endogenous counterpart. The differential pat-
tern of accumulation of M-C6-NBD-PE relative to M-C6-
NBD-PC (Fig. 1) demonstrated unequivocally that the
yeast cells distinguish between the head group structures
of these two molecules and import them to different loca-
tions. Since the diacyl glycerol portion of these two mole-
cules is identical, one can conclude that the NBD group
does not determine the uptake pathway nor does it inter-
fere with the discrimination of different head groups by
the yeast plasma membrane.
It is clear that truncation of one or both acyl chains of a
phospholipid molecule has a profound effect on its stabil-
ity in membranes. Based on the relative rates of transfer
through the water phase between liposomes, 1-palmitoyl,
2-oleoyl phosphatidylcholine is 1.4 3 105 times (23) and
dimyristoyl phosphatidylcholine is 3,000 times (23) less
likely to dissociate from a membrane into the water than
M-C6-NBD-PC (33). Thus, the usefulness of truncated
NBD-labeled lipids for studying the effect of acyl chain
length and structure on intermembrane transfer is limited.
However, as stated above, even though the truncated
NBD-labeled lipids are significantly more water soluble,
their concentration in membranes is still 107 times greater
than in water (33). Thus, even though they are readily ex-
changeable, they exist predominantly in the membrane.
PDR1 and PDR3 Regulate M-C6-NBD-PE
and Endogenous Phosphatidylethanolamine Net 
Translocation Across the Plasma Membrane
A novel mutant enrichment procedure based on photokill-
ing of cells that accumulated normal amounts of M-C6-
NBD-PE was developed to identify genes required for the
accumulation of intracellular M-C6-NBD-PE. Two genes,
originally named TPE1 and TPE2, were identified and
found to be identical to two previously identified pleiotro-
pic drug resistance genes, PDR1 (6) and PDR3 (14), re-
spectively. PDR1 and PDR3 are transcription regulators
that control the transcription of numerous genes involved
in a wide range of functions, encompassing resistance to
chemical and physical stresses, membrane transport, and
organelle function (5). Gain-of-function alleles of PDR3
mediate resistance to a wide variety of drugs by activating
transcription of the corresponding ABC transporters that
efflux the drugs out of the cells. ABC transporters shown
to be regulated by PDR3 include YOR1 (25), SNQ2 (12, 29),
and PDR5 (8, 24), which mediate the efflux of oligomycin,
4-NQO, and cycloheximide, respectively. PDR3 autoregu-
lates itself (13) and mediates resistance to other drugs as
well and is consequently believed to regulate other genes
(4, 5). PDR3 is most homologous (36% identical) and
functionally analogous to another transcriptional activator
of this PDR family, PDR1, which also mediates drug resis-
tance through the aforementioned ABC transporters. Pre-
liminary evidence suggests that PDR1 may be involved in
the regulation of a host of other genes such as PDR10,
PDR15, GAS1, glycerol-3-phosphate dehydrogenase (G3PD),
and others as well as PDR3.
The observation that M-C6-NBD-PE appears to flip-
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that the steady-state amount of M-C6-NBD-PE accumula-
tion resulting from our standard assay is determined by
the relative rates of each process. In wild-type cells, M-C6-
NBD-PE is accumulated because the rate of inward-
directed flippase activity exceeds the outward-directed ac-
tivity. Given that drug resistance is conferred by increasing
the rate of drug efflux from yeast cells and the demonstra-
tion that a mechanism for M-C6-NBD-PE efflux exists in
wild-type cells (Fig. 3), it is likely that TPE1-1/PDR1-11
and tpe2-1/pdr3-11 activate the transcription of one or
more flippases that actively transport M-C6-NBD-PE in
the outward direction. However, one cannot rule out the
possibility that these mutant alleles decrease the activity of
an inward-directed flippase either by inhibiting its tran-
scription or by activating the transcription of an inhibitor.
In addition to a decreased net inward flux of M-C6-
NBD-PE, TPE1-1/PDR1-11 and tpe2-1/pdr3-11 strains
also exhibited a four to fivefold increase in the amount of
endogenous phosphatidylethanolamine exposed in the
outer leaflet of the plasma membrane (Table II). This re-
sult supports the assertion that the observed changes in
M-C6-NBD-PE accumulation in the tpe mutants reflect al-
terations in the distribution of endogenous phosphatidyleth-
anolamine.
Identification of Flippases in Yeast
Several recent reports have identified proteins with flip-
pase activity in mammalian cells. The ABC transporters,
human MDR1 and MDR3, as well as mouse mdr2, have
been shown to have outward-directed phospholipid flip-
pase activity (40, 47, 51). This suggests the likely possibility
that the flippase responsible for the outward-directed flip-
flop of M-C6-NBD-PE will be included within a limited
class of yeast homologues of ABC transporters that con-
tain the consensus sequence for the DNA binding domain
of PDR1 in their promoter regions (5). Inward-directed
phosphatidylserine flippase activity has been reported to
be encoded by the DRS2 gene—a yeast homologue of a
bovine chromaffin granule, P-type ATPase. Deletion of
DRS2 results in the inability to internalize NBD-labeled
phosphatidylserine across the plasma membrane (49). Us-
ing our standard labeling protocol, a DRS2 deletion strain
accumulated M-C6-NBD-PE to the same extent as its
isogenic Drs21 parent strain (Grant, A.M., and J.W.
Nichols, unpublished observation). Thus, DRS2 is not
solely responsible for the internalization of M-C6-NBD-
PE. Several genetic approaches are available that should
allow the identification of the inward- and outward-
directed flippases and the mechanisms involved in the reg-
ulation of phosphatidylethanolamine transport and its
steady-state distribution across the plasma membrane.
Significance of Flippases in Unicellular Organisms
Numerous mammalian cell types (for reviews see refer-
ences 15, 16, 54), as well as the yeast Saccharomyces carl-
bergensis (9), have been reported to have an asymmetric
distribution of phospholipids across their plasma mem-
branes. In general, the aminophospholipids, phosphati-
dylserine and phosphatidylethanolamine, are sequestered
to the inner leaflet while the choline lipids, phosphatidyl-
choline and sphingomyelin, and glycolipids are concen-
trated in the outer leaflet. Establishment of this asymmet-
ric distribution is thought to result from the activity of one
or more aminophospholipid translocases that flip-flop
phosphatidylserine and phosphatidylethanolamine from
the outer to inner leaflet. Although the loss of the asym-
metric distribution of phosphatidylserine acts as a signal
for several intercellular or systemic signaling events, in-
cluding blood coagulation (39), clearance of senescent red
cells (11), and phagocytosis of apoptotic cells (17, 18), the
role of the establishment and maintenance of an asymmet-
ric phospholipid distribution for the function of single cells
has yet to be determined. It has been proposed that in-
ward-directed phosphatidylserine and/or phosphatidyleth-
anolamine translocation is required for the inward bud-
ding of the plasma membrane during endocytosis (15).
Active inward translocation of these lipids is hypothesized
to increase the phospholipid surface density in the inner
leaflet, inducing inward bending of the bilayer as predicted
by the bilayer-couple hypothesis (43). The observation
that mutant strains defective in M-C6-NBD-PE accumula-
tion (PDR1-11 and pdr3-11) are also defective in the en-
docytosis of lipid probes is consistent with this hypothesis.
Regardless of whether M-C6-NBD-PE accumulation in
the mutants is inhibited by an increased efflux or a de-
creased influx, the net result would be a loss of the ability
to establish the excess surface density in the inner leaflet
predicted to be required for inward vesicle budding.
The data presented here establish that yeast cells have
the ability to translocate M-C6-NBD-PE in the inward and
outward direction and that the net direction of transloca-
tion is under transcriptional regulation by PDR1 and
PDR3. This suggests a fundamental cellular role for phos-
pholipid flippases unrelated to intercellular signaling and
interactions. The presence of flippases that pump in oppo-
site directions suggests that yeast cells have the ability to
coordinately regulate their activities to produce dynamic
membrane perturbations or to produce an appropriate
transbilayer phospholipid distribution for their survival in a
wide range of environments during different stages of growth.
The authors wish to thank Don Wigston for the use of his microscope and
digital image analysis system.
This work was supported by National Institutes of Health grants
GM39697 and GM50915 to R.S. Fuller and by National Institutes of
Health grant GM52410 to J.W. Nichols. L.S. Kean is a recipient of a
Howard Hughes Medical Institute Predoctoral Fellowship, and A.M.
Grant is a recipient of a National Institutes of Health Minority Predoc-
toral Fellowship. Karl Kuchler was supported by a grant from the Aus-
trian Science Foundation (FWF-MOB-1023).
Received for publication 30 January 1997 and in revised form 5 June 1997.
References
1. Alani, E., L. Cao, and N. Kleckner. 1987. A method for gene disruption
that allows repeated use of URA3 selection in the construction of multi-
ply disrupted yeast strains. Genetics. 116:541–545.
2. Ames, B.N., and D.T. Dubin. 1960. The role of polyamines in the neutral-
ization of bacteriophage deoxyribonucleic acid. J. Biol. Chem. 235:769–
775.
3. Balasubramanian, K., and C.M. Gupta. 1996. Transbilayer phosphatidyl-
ethanolamine movements in the yeast plasma membrane. Evidence for a
protein-mediated, energy-dependent mechanism. Eur. J. Biochem. 240:
798–806.
4. Balzi, E., and A. Goffeau. 1994. Genetics and biochemistry of yeast multi-
drug resistance. Biochim. Biophys. Acta. 1187:152–162.
5. Balzi, E., and A. Goffeau. 1995. Yeast multidrug resistance: the PDR net-The Journal of Cell Biology, Volume 138, 1997 270
work. J. Bioenerg. Biomembr. 27:71–76.
6. Balzi, E., W. Chen, S. Ulazewski, E. Capieaux, and A. Goffeau. 1987. The
multidrug resistance gene PDR1 from Saccharomyces cerevisiae. J. Biol.
Sci. 262:16871–16879.
7. Balzi, E., M. Wang, S. Leterme, L.V. Dyck, and A. Goffeau. 1994. PDR5, a
novel yeast multidrug resistance conferring transporter controlled by the
transcriptional regulator PDR1. J. Biol. Chem. 269:2206–2214.
8. Bissinger, P.H., and K. Kuchler. 1994. Molecular cloning and expression of
the Saccharomyces cerevisiae STS1 gene product. A yeast ABC trans-
porter conferring mycotoxin resistance. J. Biol. Chem. 269:4180–4186.
9. Cerbon, J., and V. Calderon. 1991. Changes of the compositional asymme-
try of phospholipids associated to the increment in the membrane surface
potential. Biochim. Biophys. Acta. 1067:139–144.
10. Connor, J., C.H. Pak, R.F. Zwaal, and A.J. Schroit. 1992. Bidirectional
transbilayer movement of phospholipid analogs in human red blood cells.
Evidence for an ATP-dependent and protein-mediated process. J. Biol.
Chem. 267:19412–19417.
11. Connor, J., C.C. Pak, and A.J. Schroit. 1994. Exposure of phosphati-
dylserine in the outer leaflet of human red blood cells. Relationship to
cell density, cell age and clearance by mononuclear cells. J. Biol. Chem.
269:2399–2404.
12. Decottignies, A., L. Lambert, P. Catty, H. Degand, E.A. Epping, W.S.
Moye-Rowley, E. Balzi, and A. Goffeau. 1995. Identification and charac-
terization of SNQ2, a new multidrug ATP binding cassette transporter of
the yeast plasma membrane. J. Biol. Chem. 270:18150–18157.
13. Delahodde, A., T. Delaveau, and C. Jacq. 1995. Positive autoregulation of
the yeast transcription factor Pdr3p, which is involved in control of drug
resistance. Mol. Cell. Biol. 15:4043–4051.
14. Deleveau, T., A. Delahodde, E. Carvajal, J. Subik, and C. Jacq. 1994.
PDR3, a new yeast regulatory gene, is homologous to PDR1 and controls
the multidrug resistance phenomenon. Mol. Gen. Genet. 244:501–511.
15. Devaux, P.F., and A. Zachowski. 1994. Maintenance and consequences of
membrane phospholipid asymmetry. Chem. Phys. Lipids. 73:107–120.
16. Diaz, C., and A.J. Schroit. 1996. Role of translocases in the generation of
phosphatidylserine asymmetry. J. Membr. Biol. 151:1–9.
17. Fadok, V.A., J.S. Savill, C. Haslett, D.L. Bratton, D.E. Doherty, P.A.
Campbell, and P.M. Henson. 1992. Different populations of macrophages
use either the vitronectin receptor or the phosphatidylserine receptor to
recognize and remove apoptotic cells. J. Immunol. 149:4029–4035.
18. Fadok, V.A., D.R. Voelker, P.A. Campbell, J.J. Cohen, D.L. Bratton, and
P.M. Henson. 1992. Exposure of phosphatidylserine on the surface of apop-
totic lymphocytes triggers specific recognition and removal by macro-
phages. J. Immunol. 148:2207–2216.
19. Gietz, D., A.S. John, R.A. Woods, and R.H. Schiestl. 1992. Improved
method for high efficiency transformation of intact yeast cells. Nucleic
Acids Res. 20:1425.
20. Guerineau, M., P.P. Slonimski, and P.R. Avner. 1974. Yeast episome: oli-
gomycin resistance associated with a small covalently closed non-mito-
chondrial circular DNA. Biochem. Biophys. Res. Commun. 61:462–469.
21. Higgins, C.F. 1994. Flip-Flop: the transmembrane translocation of lipids.
Cell. 79:393–395.
22. Hjelmstad, R.H., and R.M. Bell. 1987. Mutants of Saccharomyces cerevisiae
defective in sn-1, 2-diacylglycerol cholinephosphotransferase. J. Biol.
Chem.  262:3909–3917.
23. Jones, J.D., and T.E. Thompson. 1990. Mechanism of spontaneous, concen-
tration-dependent phospholipid transfer between bilayers. Biochemistry.
29:1593–1600.
24. Katzmann, D., P. Burnett, J. Golin, Y. Mahe, and W.S. Moye-Rowley.
1994. Transcriptional control of the yeast PDR5 gene by the PDR3 gene
product. Mol. Cell. Biol. 14:4653–4661.
25. Katzmann, D., T.C. Hallstrom, M. Voet, W. Wysock, J. Golin, G. Volck-
aert, and W.S. Moye-Rowley. 1995. Expression of an ATP-binding cas-
sette transporter gene (YOR1) is required for oligomycin resistance in
Saccharomyces cerevisiae. Mol. Cell. Biol. 15:6875–6883.
26. Kean, L.S., R.S. Fuller, and J.W. Nichols. 1993. Retrograde lipid traffic in
yeast: identification of two distinct pathways for internalization of fluo-
rescent-labeled phosphatidylcholine from the plasma membrane. J. Cell
Biol. 123:1403–1419.
27. Lawrence, C.W. 1991. Classical mutagenesis techniques. Methods Enzy-
mol. 194:273–280.
28. Lee, K.S., J.L. Patton, M. Fido, L.K. Hines, S.D. Kohlwein, F. Paltauf, S.A.
Henry, and D.E. Levin. 1994. The Saccharomyces cerevisiae PLB1 gene
encodes a protein required for lysophospholipase and phospholipase B
activity. J. Biol. Chem. 269:19725–19730.
29. Mahe, Y., A. Parle-McDermott, A. Nourani, A. Delahodde, A. Lamprecht,
and K. Kuchler. 1996. The ATP binding cassette multidrug transporter
Snq2 of Saccharomyces cerevisiae: a novel target for the transcription fac-
tors Pdr1 and Pdr3. Mol. Microbiol. 20:109–117.
30. Marinetti, G.V., and R. Love. 1976. Differential reaction of cell membrane
phospholipids and proteins with chemical probes. Chem. Phys. Lipids.
16:239–254.
31. Martin, O.C., and R.E. Pagano. 1987. Transbilayer movement of fluores-
cent analogs of phosphatidylserine and phosphatidylethanolamine at the
plasma membrane of cultured cells. J. Biol. Chem. 262:5890–5898.
32. Monti, J.A., S.T. Christian, W.A. Shaw, and W.H. Finley. 1977. Synthesis
and properties of a fluorescent derivative of phosphatidylcholine. Life
Sci. 21:345–356.
33. Nichols, J.W. 1985. Thermodynamics and kinetics of phospholipid mono-
mer-vesicle interaction. Biochemistry. 24:6390–6398.
34. Nichols, J.W. 1987. Binding of fluorescent-labeled phosphatidylcholine to
rat liver nonspecific lipid transfer protein. J. Biol. Chem. 262:14172–
14177.
35. Nichols, J.W., and R.E. Pagano. 1983. Resonance energy transfer assay of
protein-mediated lipid transfer between vesicles. J. Biol. Chem. 258:
5368–5371.
36. Novick, P., C. Field, and R. Schekman. 1980. Identification of 23 comple-
mentation groups required for post-translational events in the yeast
secretory pathway. Cell. 21:205–215.
37. Pagano, R.E., and R.G. Sleight. 1985. Defining lipid transport pathways in
animal cells. Science (Wash. DC). 229:1051–1057.
38. Rose, M., and J. Broach. 1991. Cloning genes by complementation in yeast.
In Guide to Yeast Genetics and Molecular Biology. Vol. 194. C. Guthrie
and G.R. Fink, editors. Academic Press, Inc., San Diego. 195–230.
39. Rosing, R., G. Tans, J.W.P. Govers-Riemslag, R.F.A. Zwaal, and H.C.
Hemker. 1980. The role of phospholipids and factor Va in the prothrom-
binase complex. J. Biol. Chem. 255:274–283.
40. Ruetz, S., and P. Gros. 1994. Phosphatidylcholine translocase: a physiologi-
cal role for the mdr2 gene. Cell. 77:1071–1081.
41. Saunders, G.W., and G.H. Rank. 1982. Allelism of pleitropic drug resis-
tance in Saccharomyces cerevisiae. Can. J. Genet. Cytol. 24:493–503.
42. Schroit, A.J., and R.F.A. Zwaal. 1991. Transbilayer movement of phospho-
lipids in red cell and platelet membranes. Biochim. Biophys. Acta. 1071:
313–329.
43. Sheetz, M.P., and S.J. Singer. 1974. Biological membranes as bilayer cou-
ples: a mechanism of drug-erythrocyte interactions. Proc. Natl. Acad. Sci.
USA. 71:4457–4461.
44. Sherman, F., G.R. Fink, and J.B. Hicks. 1986. Methods in Yeast Genetics.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 164–
165.
45. Sleight, R.G., and R.E. Pagano. 1985. Transbilayer movement of a fluores-
cent phosphatidylethanolamine analog across the plasma membranes of
cultured mammalian cells. J. Biol. Chem. 260:1146–1154.
46. Smit, J.J.M., A.H. Schinkel, R.P.J. Oude Elferink, A.K. Groen, E. Wa-
genaar, L. van Deemter, C.A.A.M. Mol, R. Ottenhoff, N.M.T. van der
Lugt, M.A. van Roon, et al. 1993. Homozygous disruption of the murine
mdr2 P-glycoprotein gene leads to a complete absence of phospholipid
from bile and to liver disease. Cell. 75:451–462.
47. Smith, A.J., J.L. Timmermans-Hereijgers, B. Roelofsen, K.W. Wirtz, W.J.
van Blitterswijk, J.J. Smit, A.H. Schinkel, and P. Borst. 1994. The human
MDR3 P-glycoprotein promotes translocation of phosphatidylcholine
through the plasma membrane of fibroblasts from transgenic mice. FEBS
Lett. 354:263–266.
48. Subik, J., S. Ulaszewski, and A. Goffeau. 1986. Genetic mapping of nuclear
mucidin resistance mutations in Saccharomyces cerevisiae. A new pdr lo-
cus on chromosome II. Curr. Genet. 10:665–670.
49. Tang, X., M.S. Halleck, R.A. Schlegel, and P. Williamson. 1996. A subfam-
ily of P-Type ATPases with aminophospholipid transporting activity. Sci-
ence (Wash. DC). 272:1495–1497.
50. Thomas, B.J., and R. Rothstein. 1989. Elevated recombination rates in
transcriptionally active DNA. Cell. 56:619–630.
51. van Helvoort, A., A.J. Smith, H. Sprong, I. Fritzsche, A.H. Schinkel, P.
Borst, and G. van Meer. 1996. MDR1 p-glycoprotein is a lipid translocase
of broad specificity, while MDR3 p-glycoprotein specifically translocates
phosphatidylcholine. Cell. 87:507–517.
52. Vida, T.A., and S.D. Emr. 1995. A new vital stain for visualizing vacuolar
membrane dynamics and endocytosis in yeast. J. Cell Biol. 128:779–792.
53. Walworth, N.C., and P.J. Novick. 1987. Purification and characterization of
constitutive secretory vesicles from yeast. J. Cell Biol. 105:163–174.
54. Williamson, P., and R.A. Schlegel. 1994. Back and forth: the regulation and
function of transbilayer phospholipid movement in eukaryotic cells (Re-
view). Mol. Membr. Biol. 11:199–216.
55. Winston, F., F. Chumley, and G.R. Fink. 1993. Eviction and transplace-
ment of mutant genes in yeast. Methods Enzymol. 101:211–227.
56. Witt, W., A. Mertsching, and E. Konig. 1984. Secretion of phospholipase B
from Saccharomyces cerevisiae. Biochim. Biophys. Acta. 795:117–124.